Regulon: R-1737
Regulons
are regulatory units consisting of a coherently expressed set of genes and the associated regulator(s) whose binding site(s) they share.
Regulon Summary
Regulon summary table displays all associated information related to the specific regulon including the number of genes in the regulon, Hazard ratio
, its Regulator
, the Transcriptional Program
that includes the regulon, Drugs that are associated with members of the regulon, together with mechanism of action and class, and enriched hallmarks of cancer if any.
Genes | Cox Hazard Ratio | Regulators | Causal Flows | Transcriptional Programs | Hallmarks |
---|---|---|---|---|---|
25 | 0.632384 | 1 | 0 | Pr-121 | ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
Regulon Genes
List of genes that are included in the regulon. These genes have similar expression profiles in subset of patients and they share common binding motif for the Regulator
of the regulon. Clicking on the gene name will take you to the gene specific page with more details. Please wait while information is collated from several resources after you click.
Regulon Drugs
Name | Approved Symbol | Type | Action Type | Mechanism of Action | Max Trial Phase | Max GBM Phase |
---|---|---|---|---|---|---|
ACT-709478 | CACNA1G | Small molecule | BLOCKER | Voltage-gated T-type calcium channel blocker | 2 | 0 |
TERODILINE | CACNA1D | Small molecule | BLOCKER | Voltage-gated calcium channel blocker | 4 | 0 |
PAZOPANIB | LCK | Small molecule | INHIBITOR | Fibroblast growth factor receptor 1 inhibitor | 4 | 1 |
MIDOSTAURIN | KIT | Small molecule | INHIBITOR | Vascular endothelial growth factor receptor 2 inhibitor | 4 | 0 |
OSI-930 | KIT | Small molecule | INHIBITOR | Vascular endothelial growth factor receptor inhibitor | 1 | 0 |
TIVOZANIB | KIT | Small molecule | INHIBITOR | Vascular endothelial growth factor receptor inhibitor | 4 | 2 |
ETHOSUXIMIDE | CACNA1G | Small molecule | BLOCKER | Voltage-gated T-type calcium channel blocker | 4 | 0 |
SUNITINIB | PDGFRB | Small molecule | INHIBITOR | Platelet-derived growth factor receptor inhibitor | 4 | 2 |
AMUVATINIB | FLT3 | Small molecule | INHIBITOR | Platelet-derived growth factor receptor alpha inhibitor | 2 | 0 |
SORAFENIB TOSYLATE | PDGFRB | Small molecule | INHIBITOR | Stem cell growth factor receptor inhibitor | 4 | 2 |
DASATINIB | ABL1 | Small molecule | INHIBITOR | Platelet-derived growth factor receptor beta inhibitor | 4 | 2 |
TELATINIB | KIT | Small molecule | INHIBITOR | Vascular endothelial growth factor receptor 2 inhibitor | 2 | 0 |
SORAFENIB | FLT3 | Small molecule | INHIBITOR | Stem cell growth factor receptor inhibitor | 4 | 2 |
PEXIDARTINIB HYDROCHLORIDE | CSF1R | Small molecule | INHIBITOR | Macrophage colony stimulating factor receptor inhibitor | 4 | 0 |
SUVECALTAMIDE | CACNA1G | Small molecule | MODULATOR | Voltage-gated T-type calcium channel modulator | 2 | 0 |
PAZOPANIB HYDROCHLORIDE | LCK | Small molecule | INHIBITOR | Fibroblast growth factor receptor 1 inhibitor | 4 | 0 |
VATALANIB | KIT | Small molecule | INHIBITOR | Platelet-derived growth factor receptor inhibitor | 3 | 1 |
PHENSUXIMIDE | CACNA1G | Small molecule | BLOCKER | Voltage-gated T-type calcium channel blocker | 4 | 0 |
PARAMETHADIONE | CACNA1G | Small molecule | BLOCKER | Voltage-gated T-type calcium channel blocker | 4 | 0 |
TANDUTINIB | FLT3 | Small molecule | INHIBITOR | Platelet-derived growth factor receptor beta inhibitor | 2 | 2 |
FORETINIB | TEK | Small molecule | INHIBITOR | Tyrosine-protein kinase TIE-2 inhibitor | 2 | 0 |
IMATINIB MESYLATE | ABL1 | Small molecule | INHIBITOR | Bcr/Abl fusion protein | 4 | 3 |
SUNITINIB MALATE | PDGFRB | Small molecule | INHIBITOR | Platelet-derived growth factor receptor inhibitor | 4 | 2 |
XL-999 | PDGFRB | Small molecule | INHIBITOR | Fibroblast growth factor receptor inhibitor | 2 | 0 |
DOVITINIB | PDGFRB | Small molecule | INHIBITOR | Vascular endothelial growth factor receptor inhibitor | 3 | 1 |
SU-014813 | PDGFRB | Small molecule | INHIBITOR | Vascular endothelial growth factor receptor inhibitor | 2 | 0 |
ENMD-2076 | FLT3 | Small molecule | INHIBITOR | Tyrosine-protein kinase receptor FLT3 inhibitor | 2 | 0 |
ANLOTINIB | KIT | Small molecule | INHIBITOR | Vascular endothelial growth factor receptor 3 inhibitor | 3 | 2 |
METHSUXIMIDE | CACNA1G | Small molecule | BLOCKER | Voltage-gated T-type calcium channel blocker | 4 | 0 |
IMATINIB | ABL1 | Small molecule | INHIBITOR | Bcr/Abl fusion protein | 4 | 3 |
GABAPENTIN ENACARBIL | CACNA1D | Small molecule | MODULATOR | Voltage-gated calcium channel modulator | 4 | 0 |
TRIMETHADIONE | CACNA1G | Small molecule | BLOCKER | Voltage-gated T-type calcium channel blocker | 4 | 0 |
PREGABALIN | CACNA1D | Small molecule | MODULATOR | Voltage-gated calcium channel modulator | 4 | 0 |
XL-820 | KIT | Small molecule | INHIBITOR | Platelet-derived growth factor receptor inhibitor | 2 | 0 |
ATAGABALIN | CACNA1D | Small molecule | MODULATOR | Voltage-gated calcium channel modulator | 2 | 0 |
GABAPENTIN | CACNA1D | Small molecule | MODULATOR | Voltage-gated calcium channel modulator | 4 | 0 |
MASITINIB | KIT | Small molecule | INHIBITOR | Stem cell growth factor receptor inhibitor | 3 | 0 |
SEMAXANIB | KDR | Small molecule | INHIBITOR | Vascular endothelial growth factor receptor inhibitor | 3 | 0 |
MOTESANIB | KDR | Small molecule | INHIBITOR | Tyrosine-protein kinase receptor RET inhibitor | 3 | 0 |
BEPRIDIL | CACNA1D | Small molecule | BLOCKER | Voltage-gated calcium channel blocker | 4 | 0 |
PEXIDARTINIB | FLT3 | Small molecule | INHIBITOR | Macrophage colony stimulating factor receptor inhibitor | 4 | 2 |
SULOCTIDIL | CACNA1D | Small molecule | BLOCKER | Voltage-gated calcium channel blocker | 4 | 0 |
QUIZARTINIB | PDGFRB | Small molecule | INHIBITOR | Tyrosine-protein kinase receptor FLT3 inhibitor | 3 | 0 |
IMAGABALIN | CACNA1D | Small molecule | MODULATOR | Voltage-gated calcium channel modulator | 3 | 0 |
AVAPRITINIB | PDGFRA | Small molecule | INHIBITOR | Platelet-derived growth factor receptor alpha inhibitor | 4 | 0 |
AMG-191 | KIT | Antibody | INHIBITOR | Stem cell growth factor receptor inhibitor | 1 | 0 |
CM-082 | FLT3 | Small molecule | INHIBITOR | Vascular endothelial growth factor receptor 2 inhibitor | 3 | 0 |
CEDIRANIB | KIT | Small molecule | INHIBITOR | Platelet-derived growth factor receptor inhibitor | 3 | 3 |
REGORAFENIB | KDR | Small molecule | INHIBITOR | Tyrosine-protein kinase TIE-2 inhibitor | 4 | 2 |
MIBEFRADIL | CACNA1G | Small molecule | BLOCKER | Voltage-gated T-type calcium channel blocker | 4 | 1 |
FAMITINIB | KDR | Small molecule | INHIBITOR | Platelet-derived growth factor receptor inhibitor | 3 | 0 |
RIPRETINIB | KIT | Small molecule | INHIBITOR | Platelet-derived growth factor receptor alpha inhibitor | 4 | 0 |
TIVOZANIB HYDROCHLORIDE | KIT | Small molecule | INHIBITOR | Vascular endothelial growth factor receptor inhibitor | 4 | 0 |
Causal Flows
Causal Flows
are statistically significant links between putative causal events (somatic mutations, copy number variations, chromosomal translocations, etc.) and the activity levels of regulators and regulons. In the causal flow a mutation
may causally activates or deactivates a downstream regulator
which then might up- or down-regulates a regulon
that contains genes with similar expression profiles and binding sites.
Causal Mechanistic Flows for Regulon R-1737
ID | Mutation | Role | Regulator | Role | Regulon | # downstream regulons | # diffexp regulons | Drugs |
---|